Ken Griffin Bausch Health Companies Inc. Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 887,000 shares of BHC stock, worth $6.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

887,000

Previous 1,726,100 48.61%

Holding current value

$6.6 Million

Previous $14.1 Million 49.18%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.34 - $9.78 $409,601 - $545,763	55,804 Added 1.08%	5,200,796 $41.9 Million
Q3 2024 Nov 14, 2024	SELL	$5.22 - $8.26 $10.1 Million - $16 Million	-1,932,314 Reduced 27.3%	5,144,992 $41.9 Million
Q2 2024 Aug 14, 2024	BUY	$6.1 - $10.41 $19.7 Million - $33.6 Million	3,225,724 Added 83.75%	7,077,306 $49.3 Million
Q1 2024 May 15, 2024	SELL	$7.77 - $10.61 $23.2 Million - $31.7 Million	-2,987,389 Reduced 43.68%	3,851,582 $40.9 Million
Q4 2023 Feb 14, 2024	BUY	$6.53 - $8.23 $4.68 Million - $5.9 Million	716,815 Added 11.71%	6,838,971 $54.8 Million
Q3 2023 Nov 14, 2023	BUY	$7.69 - $9.71 $30.4 Million - $38.4 Million	3,955,893 Added 182.61%	6,122,156 $50.3 Million
Q2 2023 Aug 14, 2023	BUY	$5.72 - $8.8 $9.53 Million - $14.7 Million	1,666,151 Added 333.16%	2,166,263 $17.3 Million
Q1 2023 May 15, 2023	SELL	$6.28 - $9.85 $4.77 Million - $7.48 Million	-759,039 Reduced 60.28%	500,112 $4.05 Million
Q4 2022 Feb 14, 2023	SELL	$6.09 - $7.93 $4.08 Million - $5.32 Million	-670,719 Reduced 34.75%	1,259,151 $7.91 Million
Q3 2022 Nov 14, 2022	BUY	$4.58 - $9.21 $1.18 Million - $2.37 Million	257,334 Added 15.39%	1,929,870 $13.3 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $3.65 Million - $12.2 Million	517,280 Added 44.78%	1,672,536 $14 Million
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $5.87 Million - $7.55 Million	-271,567 Reduced 19.03%	1,155,256 $26.4 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $2.76 Million - $3.47 Million	119,786 Added 9.16%	1,426,823 $39.4 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $11.3 Million - $13.6 Million	-451,150 Reduced 25.66%	1,307,037 $36.4 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $14.9 Million - $17.7 Million	542,224 Added 44.59%	1,758,187 $51.6 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $21.3 Million - $34.2 Million	-994,684 Reduced 45.0%	1,215,963 $38.6 Million
Q4 2020 Feb 16, 2021	SELL	$15.31 - $21.12 $4.07 Million - $5.61 Million	-265,733 Reduced 10.73%	2,210,647 $46 Million
Q3 2020 Nov 16, 2020	BUY	$14.88 - $20.13 $31.7 Million - $42.8 Million	2,127,333 Added 609.47%	2,476,380 $38.5 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $4.43 Million - $6.82 Million	-332,621 Reduced 48.8%	349,047 $6.38 Million
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $1.03 Million - $2.41 Million	79,628 Added 13.23%	681,668 $10.6 Million
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $9.94 Million - $16.8 Million	-525,981 Reduced 46.63%	602,040 $18 Million
Q3 2019 Nov 14, 2019	BUY	$20.88 - $25.66 $8.88 Million - $10.9 Million	425,135 Added 60.48%	1,128,021 $24.6 Million
Q2 2019 Aug 14, 2019	SELL	$20.52 - $26.45 $24,439 - $31,501	-1,191 Reduced 0.17%	702,886 $17.7 Million
Q1 2019 May 15, 2019	SELL	$20.23 - $26.29 $39.7 Million - $51.6 Million	-1,964,183 Reduced 73.61%	704,077 $0
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $26.4 Million - $42.3 Million	1,494,492 Added 127.32%	2,668,260 $49.3 Million
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $24.2 Million - $30.1 Million	1,173,768 New	1,173,768 $0

Others Institutions Holding BHC

# of Institutions

271

Shares Held

252M

Call Options Held

5.12M

Put Options Held

9.43M

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.69B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account